摘要 |
A method for delaying or preventing the onset of Type 1 diabetes in a human or non-human mammal, which method comprises the administration of an effective, non-toxic and pharmaceutically acceptable amount of a PPAR agonist, such Compound (I), or a pharmaceutically acceptable derivative thereof, to the patient in need thereof. |